Home > Insider Trading > Filing (0001127602-20-012450)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1757584	David James Clark	One Cvs Drive Woonsocket RI 02895	Svp, Cont & Chief Acct Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-30	3,030	$54.53	12,790	No	4	M	Direct
Common Stock	Disposition	2020-03-30	3,030	$60.00	9,760	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2020-03-30	3,030	$0.00	3,030	$54.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2014-04-01	2020-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock (Restricted)	14,733	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$74.29	2015-04-01	2021-04-01	5,350	5,350	Direct
Common Stock	Stock Option	$102.26	2016-04-01	2022-04-01	6,059	6,059	Direct
Common Stock	Stock Option	$104.82	2017-04-01	2023-04-01	7,044	7,044	Direct
Common Stock	Stock Option	$78.05	2018-04-03	2024-04-03	9,050	9,050	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	7,513	7,513	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	24,240	24,240	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-04-01	5,350	5,350	Direct
2022-04-01	6,059	6,059	Direct
2023-04-01	7,044	7,044	Direct
2024-04-03	9,050	9,050	Direct
2025-04-01	7,513	7,513	Direct
2029-04-01	24,240	24,240	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 plan.
Remaining options became exercisable in four equal annual installments beginning on 4/1/2014.
Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.
Options became exercisable in four equal annual installments beginning on 4/1/2016.
Options became exercisable in four equal annual installments beginning on 4/1/2017.
Options became exercisable in four equal annual installments beginning on 4/3/2018.
Options became exercisable in four equal annual installments, commencing 4/1/2019.
Options became exercisable in four equal annual installments, commencing 4/1/2020.